Some psychedelic compounds have been shown to be powerful promoters of growth in atrophied cortical neurons, a fact that has intrigued researchers interested in addressing one of the hallmark…
Read More
Considerable effort has been made in recent years to evaluate—or in some cases, reevaluate—psychedelic drugs for potential use as therapeutics to treat, among other things, psychiatric disorders such…
Read More
Among those studying psychedelic drugs to treat psychiatric illnesses, there is new research exploring the possibility that structurally modified versions of these agents may reduce or eliminate…
Read More
In an exploratory and preliminary clinical test, a team of researchers at Stanford University has obtained “initial evidence” suggesting that a psychoactive compound called ibogaine, when co-…
Read More
